Sky High Fund is a venture capital firm investing in Seed to Series A companies across AgTech, biotechnology, healthcare, life sciences, medical devices, pharmaceuticals and oncology. It typically leads rounds with initial checks of $500K to $1M, targets 5-25% ownership, and supports founders with strategic guidance, talent, business development, follow-on fundraising and access to industry experts and partners. Its investment activity includes the United States.